Vaccines for preventing typhoid fever
R Milligan, M Paul, M Richardson… - Cochrane Database of …, 2018 - cochranelibrary.com
Background Typhoid fever and paratyphoid fever continue to be important causes of illness
and death, particularly among children and adolescents in south‐central and southeast …
and death, particularly among children and adolescents in south‐central and southeast …
[HTML][HTML] Typhoid and paratyphoid fever: a call to action
The advent of new generation TCVs offers us a practical and affordable public-health tool
that–for the first time–can be integrated into routine childhood immunization programmes. In …
that–for the first time–can be integrated into routine childhood immunization programmes. In …
[HTML][HTML] Burden of typhoid and paratyphoid fever in India
J John, A Bavdekar… - … England Journal of …, 2023 - Mass Medical Soc
Background In 2017, more than half the cases of typhoid fever worldwide were projected to
have occurred in India. In the absence of contemporary population-based data, it is unclear …
have occurred in India. In the absence of contemporary population-based data, it is unclear …
[HTML][HTML] Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of …
Summary Background Salmonella enterica serovar Typhi (S Typhi) is responsible for an
estimated 20 million infections and 200 000 deaths each year in resource poor regions of …
estimated 20 million infections and 200 000 deaths each year in resource poor regions of …
Progress in typhoid fever epidemiology
JA Crump - Clinical Infectious Diseases, 2019 - academic.oup.com
Salmonella enterica subspecies enterica serovar Typhi (Salmonella Typhi) is the cause of
typhoid fever and a human host–restricted organism. Our understanding of the global …
typhoid fever and a human host–restricted organism. Our understanding of the global …
[HTML][HTML] Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind …
N Nampota-Nkomba, OM Nyirenda… - The Lancet Global …, 2022 - thelancet.com
Background Typhoid fever is a substantial public health problem in Africa, yet there are few
clinical trials of typhoid conjugate vaccine (TCV). We assessed immunogenicity and safety of …
clinical trials of typhoid conjugate vaccine (TCV). We assessed immunogenicity and safety of …
Indian academy of pediatrics (IAP) advisory committee on vaccines and immunization practices (ACVIP) recommended immunization schedule (2018-19) and update …
Justification There is a need to revise/review recommendations regarding existing vaccines
in view of current developments in vaccinology. Process Advisory Committee on Vaccines …
in view of current developments in vaccinology. Process Advisory Committee on Vaccines …
British infection association guidelines for the diagnosis and management of enteric fever in England
LE Nabarro, N McCann, MT Herdman, C Dugan… - Journal of Infection, 2022 - Elsevier
Enteric fever (EF) is an infection caused by the bacteria called Salmonella Typhi or
Paratyphi. Infection is acquired through swallowing contaminated food or water. Most EF in …
Paratyphi. Infection is acquired through swallowing contaminated food or water. Most EF in …
[HTML][HTML] Recent advances in the synthesis of glycoconjugates for vaccine development
C Colombo, O Pitirollo, L Lay - Molecules, 2018 - mdpi.com
During the last decade there has been a growing interest in glycoimmunology, a relatively
new research field dealing with the specific interactions of carbohydrates with the immune …
new research field dealing with the specific interactions of carbohydrates with the immune …
Occurrence of typhoid fever complications and their relation to duration of illness preceding hospitalization: a systematic literature review and meta-analysis
LM Cruz Espinoza, E McCreedy, M Holm… - Clinical Infectious …, 2019 - academic.oup.com
Background Complications from typhoid fever disease have been estimated to occur in 10%–
15% of hospitalized patients, with evidence of a higher risk in children and when delaying …
15% of hospitalized patients, with evidence of a higher risk in children and when delaying …